Overview
Hemoglobin M disease is a rare inherited blood disorder in which an abnormal form of hemoglobin, called hemoglobin M, is present in the red blood cells. Hemoglobin is the protein in red blood cells that carries oxygen throughout your body. In this condition, a genetic mutation changes the hemoglobin molecule so that the iron within it gets locked in a form called methemoglobin. Methemoglobin cannot carry oxygen effectively. This leads to a condition called methemoglobinemia, where the blood has a reduced ability to deliver oxygen to the body's tissues. The most noticeable symptom of hemoglobin M disease is cyanosis — a bluish or slate-gray discoloration of the skin, lips, and nail beds — that is present from birth or early infancy. Despite this alarming appearance, most people with hemoglobin M disease are surprisingly well and do not experience severe health problems. The cyanosis occurs because of the brownish color of methemoglobin in the blood rather than because of dangerously low oxygen levels. Some individuals may experience mild shortness of breath or fatigue, especially during exercise, but many people live normal, healthy lives. There is no specific cure for hemoglobin M disease, and in most cases, treatment is not necessary because the condition is generally benign. Unlike other forms of methemoglobinemia, hemoglobin M disease does not respond well to methylene blue, which is the standard treatment for acquired or other genetic forms of methemoglobinemia. The most important aspect of management is accurate diagnosis to avoid unnecessary treatments and to provide reassurance to patients and families.
Also known as:
Key symptoms:
Bluish or grayish skin color (cyanosis) present from birthBlue or dark-colored lipsBlue or dusky fingernails and toenailsBrownish-colored bloodMild shortness of breath during exerciseMild fatigue or reduced exercise toleranceSlate-gray skin tone that does not improve with oxygen therapy
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hemoglobin M disease.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hemoglobin M disease at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hemoglobin M disease.
Community
No community posts yet. Be the first to share your experience with Hemoglobin M disease.
Start the conversation →Latest news about Hemoglobin M disease
No recent news articles for Hemoglobin M disease.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific hemoglobin M variant does my family member have, and which gene is affected?,Are there any medications or substances we should avoid that could worsen the methemoglobinemia?,Should other family members be tested for this condition?,Are there any activity restrictions, or can my child participate in sports normally?,What should I tell emergency room doctors if we need urgent care for an unrelated problem?,Is genetic counseling recommended for future family planning?,How often should follow-up blood tests or check-ups be done?
Common questions about Hemoglobin M disease
What is Hemoglobin M disease?
Hemoglobin M disease is a rare inherited blood disorder in which an abnormal form of hemoglobin, called hemoglobin M, is present in the red blood cells. Hemoglobin is the protein in red blood cells that carries oxygen throughout your body. In this condition, a genetic mutation changes the hemoglobin molecule so that the iron within it gets locked in a form called methemoglobin. Methemoglobin cannot carry oxygen effectively. This leads to a condition called methemoglobinemia, where the blood has a reduced ability to deliver oxygen to the body's tissues. The most noticeable symptom of hemoglobi
How is Hemoglobin M disease inherited?
Hemoglobin M disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hemoglobin M disease typically begin?
Typical onset of Hemoglobin M disease is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Hemoglobin M disease?
16 specialists and care centers treating Hemoglobin M disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.